MARPAI INC-CLASS A (MRAI) Stock Price, Quote, News and Overview
NASDAQ:MRAI - Nasdaq - US5713542083 - Common Stock - Currency: USD
MRAI Quote, Performance and Key Statistics
0.9
-1.04 (-53.61%)
The current stock price of MRAI is 0.9 USD. In the past month the price decreased by -56.52%. In the past year, price decreased by -65.89%.
MRAI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MMC | MARSH & MCLENNAN COS | 26.14 | 112.96B | ||
| AON | AON PLC-CLASS A | 24.77 | 84.25B | ||
| AJG | ARTHUR J GALLAGHER & CO | 32.11 | 81.39B | ||
| WTW | WILLIS TOWERS WATSON PLC | 19.29 | 32.53B | ||
| BRO | BROWN & BROWN INC | 29.09 | 31.95B | ||
| RYAN | RYAN SPECIALTY HOLDINGS INC | 36.53 | 17.12B | ||
| BWIN | BALDWIN INSURANCE GROUP INC/ | 28.6 | 4.61B | ||
| GSHD | GOOSEHEAD INSURANCE INC -A | 71.6 | 3.96B | ||
| HGTY | HAGERTY INC-A | 41.63 | 3.41B | ||
| ABLLL | ABACUS LIFE INC - ABL 9 7/8 11/15/28 | 68.08 | 2.57B | ||
| SLQT | SELECTQUOTE INC | N/A | 786.68M | ||
| ABL | ABACUS LIFE INC | 19.77 | 745.09M |
Related stock screener links
About MRAI
Company Profile
Marpai Inc is a US-based company operating in Insurance industry. The company is headquartered in Tampa, Florida and currently employs 303 full-time employees. The company went IPO on 2021-10-27. Marpai, Inc. is a technology-driven healthcare company, which uses artificial intelligence (AI) and data analytics. The firm provides administrative services and acts as a third-party administrator (TPA) to self-insured employers who provide healthcare benefits to their employees. The Company’s clients are small and medium-sized companies, as well as local government entities. The company provides services to a total of over 41,000 of its client’s employees, including their spouses and dependents. The company serves a total of approximately 73,000 members in 44 states in addition to the District of Columbia. The Company’s AI-powered TopCare program became live, making it possible for it to offer care management with predictions. The Company’s wholly owned subsidiaries include Marpai Captive, Inc., Marpai Administrators, LLC, Marpai Health, Inc., EYME Technologies, Ltd. and Maestro Health, LLC.
Company Info
MARPAI INC-CLASS A
615 Channelside Drive, Suite 207
Tampa FLORIDA US
Employees: 303
Company Website: https://www.marpaihealth.com/
Phone: 16463033483
MARPAI INC-CLASS A / MRAI FAQ
What is the stock price of MARPAI INC-CLASS A today?
The current stock price of MRAI is 0.9 USD. The price decreased by -53.61% in the last trading session.
What is the ticker symbol for MARPAI INC-CLASS A stock?
The exchange symbol of MARPAI INC-CLASS A is MRAI and it is listed on the Nasdaq exchange.
On which exchange is MRAI stock listed?
MRAI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MARPAI INC-CLASS A stock?
7 analysts have analysed MRAI and the average price target is 6.12 USD. This implies a price increase of 580% is expected in the next year compared to the current price of 0.9. Check the MARPAI INC-CLASS A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MARPAI INC-CLASS A worth?
MARPAI INC-CLASS A (MRAI) has a market capitalization of 9.28M USD. This makes MRAI a Nano Cap stock.
How many employees does MARPAI INC-CLASS A have?
MARPAI INC-CLASS A (MRAI) currently has 303 employees.
Is MARPAI INC-CLASS A (MRAI) expected to grow?
The Revenue of MARPAI INC-CLASS A (MRAI) is expected to decline by -2.59% in the next year. Check the estimates tab for more information on the MRAI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MARPAI INC-CLASS A (MRAI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MRAI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MRAI, evaluating the profitability, health, valuation and growth aspects
- MARPAI INC-CLASS A (MRAI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MARPAI INC-CLASS A (MRAI) Sales and EPS estimates to see what analysts future expectations are.
- MARPAI INC-CLASS A (MRAI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MARPAI INC-CLASS A (MRAI) Insider and Institutional Ownership to learn about the owners and their transactions.
- MARPAI INC-CLASS A (MRAI) Stock Chart to make your own analysis
- MARPAI INC-CLASS A (MRAI) Latest news and press-releases to stay up to date.
Does MARPAI INC-CLASS A (MRAI) stock pay dividends?
MRAI does not pay a dividend.
When does MARPAI INC-CLASS A (MRAI) report earnings?
MARPAI INC-CLASS A (MRAI) will report earnings on 2024-08-01, after the market close.
What is the Price/Earnings (PE) ratio of MARPAI INC-CLASS A (MRAI)?
MARPAI INC-CLASS A (MRAI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.16).
What is the Short Interest ratio of MARPAI INC-CLASS A (MRAI) stock?
The outstanding short interest for MARPAI INC-CLASS A (MRAI) is 0.38% of its float. Check the ownership tab for more information on the MRAI short interest.
MRAI Technical Analysis
MRAI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MRAI. Both the profitability and financial health of MRAI have multiple concerns.
MRAI Financial Highlights
Over the last trailing twelve months MRAI reported a non-GAAP Earnings per Share(EPS) of -3.16. The EPS increased by 45.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -80.54% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MRAI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to MRAI. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 66.51% and a revenue growth -2.59% for MRAI